STATE OF WISCONSIN et al v. INDIVIOR INC. et al

Filing 525

ORDER THAT THE MOTION FOR SUMMARY JUDGMENT BY DEFENDANT AQUESTIVE THERAPEUTICS INC. IS GRANTED. JUDGMENT IS ENTERED IN FAVOR OF DEFENDANT AQUESTIVE THERAPEUTICES INC. AND AGAINST PLAINTIFF STATES ON ALL CLAIMS AGAINST AQUESTIVE. SIGNED BY HONORABLE MITCHELL S. GOLDBERG ON 10/19/22. 10/20/22 ENTERED AND COPIES E-MAILED. (SEE 13MD2445; DOC #840)(mbh)

Case 2:16-cv-05073-MSG Document 525 Filed 10/19/22 Page 1 of 1

IN THE UNITED STATES DISTRICT COURT
FOR THE EASTERN DISTRICT OF PENNSYLVANIA
___________________________________________
:
IN RE SUBOXONE (BUPRENORPHINE
:
MDL NO. 2445
HYDROCHLORIDE AND NALOXONE)
:
13-MD-2445
ANTITRUST LITIGATION
:
:
THIS DOCUMENT RELATES TO:,
:
:
Wisconsin, et al. v. Indivior Inc. et al.
:
Case No. 16-cv-5073
:
__________________________________________ :
STATE OF WISCONSIN
:
By Attorney General Brad D. Schimel, et al.
:
:
CIV. A. NO. 16-5073
Plaintiffs,
:
v.
:
:
INDIVIOR INC. f/k/a RECKITT BENCKISER
:
PHARMACEUTICALS, INC., et al.
:
:
Defendants.
:
___________________________________________ :
ORDER
AND NOW, this 19th day of October, 2022, upon consideration of the Motion for Summary
Judgment by Defendant Aquestive Therapeutics, Inc. (“Aquestive”) (MDL No. 13-2445, Doc. Nos. 702,
704; Civ. A. No. 16-5073, Doc No. 452), the Response by Plaintiffs State of Wisconsin, et al. (“States”)
(MDL No. 13-2445, Doc. Nos. 726, 729; Civ. A. No. 16-5073, Doc Nos. 460, 466), Aquestive’s Reply
(MDL No. 13-2445, Doc. Nos. 744, 750; Civ. A. No. 16-5073, Doc No. 472), and the States’ Sur-reply
(MDL No. 13-2445, Doc. Nos. 757, 758; Civ. A. No. 16-5073, Doc Nos. 477, 478), and following oral
argument on the Motion, it is hereby ORDERED that the Motion is GRANTED.
JUDGMENT IS ENTERED in favor of Defendant Aquestive Therapeutics, Inc. and against
Plaintiff States on all claims against Aquestive.
BY THE COURT:
/s/ Mitchell S. Goldberg
MITCHELL S. GOLDBERG, J.